Senior Pre-Formulation Scientist - South East - c45,000 + excellent benefits
My client is a global pharmaceutical company specialising in the discovery and development of therapies for life-threatening diseases.
A position has now become available for a high calibre pre-formulation scientist to join the Pharmaceutical Chemistry group.
The primary responsibilities include: - Laboratory research into physical and chemical properties of pharmaceutical materials. - Work with compounds during pre-clinical development phase from early discovery and lead opt to early toxicology and pharmaceutical studies. - Develop drug forms and formulations to optimize exposure and stability. - Regular involvement with other departments to drive efficiency and effectiveness of company drug development.
This position requires and exceptional pre-formulation scientist with the ability to work autonomously to achieve research success. Excellent understanding of solid-state chemistry including structure and physical aspects of small molecule pharmaceuticals, is essential. Experience working with pharmaceutical compounds at pre-clinical phase leading to toxicology and pharmacology studies is required. In addition, the successful applicant will have a PhD (or equivalent in Chemistry, Physical Chemistry, Materials Science, Pharmaceutics or related field. Excellent laboratory skills in pre-formulation including solid-state (XRPD, DSC, TGA & DVS and analytical techniques including HPLC and NMR.
Applicants will be expected to be an expert in their field and display and excellent understanding of early stage pharmaceutical drug discovery.
This is an exceptional opportunity for an exceptional candidate.
The package includes and annual salary of c?45,000 within additional bonus package and excellent benefits.
Interested? Apply online now or contact PULSE Scientific on 01235 861732.
All applicants must be in a position to prove that they are legally entitled to work in the UK and accept employment without infringement of their immigration status.
ASSISTANT PROFESSOR HEALTH SERVICES/OUTCOMES RESEARCH POSITIONS AND RESPONSIBILITIES: The Department of Pharmaceutical Systems and Policy at the West Virginia University (WVU School of Pharmacy seeks applications for an Assistant Professor to join our health services/outcomes research team. This 12-month tenure track position is available immediately. Primary responsibilities include graduate and professional program teaching, graduate student mentoring, and developing an independently funded research program in health services and outcomes research. Salary and start-up packages are competitive. QUALIFICATIONS: Ph.D. or equivalent degree with a strong research focus in patient-reported outcomes (e.g., Health Related Quality of Life, patient satisfaction , or chronic disease epidemiology. Candidates should have a promise for excellence in research and teaching in relevant areas, as well as peer-reviewed publications. Experience and participation in funded research is an advantage and excellent communication skills are important. Candidates should interact effectively with collaborators from diverse disciplines and be eligible for appointment to the graduate faculty in order to teach and mentor graduate students engaged in health services and outcomes research. APPLICATION: Interested persons should submit an application consisting of a letter of interest, curriculum vitae, and contact information for three professional references to: Usha Sambamoorthi, Ph.D., West Virginia University School of Pharmacy, PO Box 9510, Morgantown, WV 26506 or by e-mail to usambamoorthi@hsc.wvu.edu with a copy to acframe@hsc.wvu.edu. Applications will be considered as they are received and will be accepted until position is filled. SCHOOL AND COMMUNITY: The School of Pharmacy has a nationally recognized Ph.D. graduate program in health outcomes research with 15 Ph.D. students, the majority of whom are supported by external research funding. It offers exciting opportunities through the Rational Drug Therapy Program which is supported by West Virginia state agencies, the AHRQ funded West Virginia Collaborative Health Outcomes Research of Therapies and Services (CoHORTS center, and the newly established Wigner Institute for Advanced Pharmacy Practice Education and Research. Established partnerships with the state Medicaid program and the state health insurance program, managed care organizations, several pharmaceutical companies, and the nearby National Institute of Occupational Safety and Health (N.I.O.S.H. and Mylan Pharmaceuticals offer potential opportunities for collaborative research. In addition, a newly launched School of Public Health and research faculty and graduate programs in business, communication, education, psychology, public administration, and sociology provide opportunities for multidisciplinary collaboration and research. The School of Pharmacy is situated within a large state-assisted academic health sciences center which includes a 460-bed teaching hospital, a psychiatric hospital, rehabilitation hospital, and regional cancer center. West Virginia University (a Doctoral Research-Intensive University is the state's land-grant university with an enrollment of 29,000 students. WVU is located in Morgantown, a scenic rural area that has been featured in numerous publications for its high quality of life, cultural amenities, outdoor recreation, and is within easy driving distance to Pittsburgh, PA, and Washington, DC. West Virginia University is an Equal Opportunity/Affirmative Action Employer. Women and minorities are encouraged to apply. The WVU Health Sciences Center is a smoke free campus. West Virginia University is the recipient of an NSF ADVANCE award for gender equity.
Post : Business Analyst in Pharmaceutical Research
Experience : 0 to 2 yrs
Job Desciption : a. Track the pharmaceutical, biotech and medical devices industry, especially therapeutic areas/modalities of interest to our regular clients b. Understand project brief given by clients/project leaders, create analysis plan, data requirements, research approach, and prepare reports or executive presentations with key insights and recommendations c. Report to project leader/consultant and assist in executing or execute the projects completely depending on complexity and scale Education : M.Sc - Bio-Chemistry, Biotechnology , Life Science
Salary : INR 1,75,000 - 2,50,000 P.A. The CTC is exclusive of Performance Bonus
Desirable : a. High level of comfort with MS Excel, Power Point, ability to perform basic calculations (basic financial, statistical and data manipulation understand sales and marketing performance metrics, basic data cleaning and organizing, ability to create meaningful charts/ visual representation to simplify complex analyses. b. Web search, high level of familiarity with life sciences lexicon, regulatory framework for pharmaceuticals and biotech c. Attention to detail, accuracy, business relevance in analysis and report writing/executive presentation skills
Location : Bangalore
Contact Details : Executive Name : Ravi Prakash Stratycon Business Solutions Pvt Ltd Address : 14th cross, 2nd block, Jayanagar Bangalore,Karnataka,India 560011 Email Address : raviprakash@stratycon.com
Location: NJ Salary: 110000 Description: The position requires demonstrated expertise in general mammalian toxicology. The position will oversee the conduct of general toxicity and drug safety studies in accordance with current scientific and applicable regulatory standards (ICH, FDA and GLPs and will monitor safety studies related to drug registration. Preferably, the incumbent will be specialized in one or more of the following areas: general safety evaluation, genetic toxicology, safety pharmacology, reproductive toxicology, carcinogenicity evaluation. In addition, he/she is expected to provide technical leadership in non-clinical drug safety assessment in support of worldwide clinical and preclinical R&D. The incumbent will be required to make both informal and formal presentations to internal staff and project teams and may be asked to assist with presentations to senior management as well as providing project team representation and active involvement in process development. The incumbent will be expected to contribute to the preparation of relevant sections of drug registration submissions. Knowledge of the drug development process and experience in interaction with scientific disciplines such as pharmacokinetics, metabolism, medical research and clinical pharmacology are essential. A successful track record of toxicology testing program management, innovative thinking, execution and timely delivery of reports and regulatory submissions is helpful. PRINCIPAL ACCOUNTABILITIES: Direct responsibilities will include, but are not limited to the following: o Participation in the evaluation and qualification of CROs. o Assists in the design of study protocols for nonclinical toxicology and safety pharmacology studies for conduct at CROs. o Conduct, monitor, and manage toxicology studies at CROs. This will involve limited travel (~10% . o Reviews study data and reviews/revises final study reports for department authorization. o Assists in the preparation of the nonclinical safety sections of regulatory submissions for registration/marketing authorizations of new drug products o Provide technical expertise to support project teams goals and objectives. Educational Requirements A minimum MS in pharmacology, toxicology, biochemistry or related science is required. At least 5 - 7 years industry (preferably pharmaceutical experience with 3 + years' experience in the conduct of mammalian toxicology studies. Required Experience & Technical Requirements o Knowledge and expertise in toxicology and standard and alternative toxicology test methods is necessary to address the range of varied chemical substances that will need to be tested and to interpret and report the study results. o Knowledge of GLPs and direct experience in toxicology testing and/or study management is needed to successfully prepare protocols, implement, and adequately oversee the toxicity studies conducted by CROs and to understand the relative strengths and limitations of testing methods as they relate to hazard identification. o Knowledge and experience in internet/database searching is necessary to develop information that will allow the avoidance of duplicative and unwarranted use of animals in toxicology testing and to assure up-to-date and complete knowledge of available toxicology data and regulatory changes and initiatives. This includes but is not limited to experience in successfully searching FDA, EMEA, WHO, NTP, ASTDR, IARC, NLM databases. o Concise and accurate writing skills and clear and effective oral presentation skills. Contact: dld@judge.com This job and many more are available through The Judge Group. Find us on the web at www.judge.com
Biotecnika Info Labs Pvt Ltd, Bangalore is a Parent Company which runs India’s Largest Biosciences Career & education Portal. Biotecnika is where in technology meets life sciences.
“We are a fast growing Bio-techno-media company with extremely talented and fun Loving people you would love to work with. Biotecnika is run by a group of Doctorate & post Doctorates of lifesciences & together we help in the upliftment of postgraduates from any lifesciences background. If you do not like processes, hate pyramid type organizations; love creativity, innovation and fun at work; you will love it here. You will find a very flexible work environment, which treats people like human beings”
Post: Business Development Executive
Company Name: Biotecnika Info Labs Pvt Ltd
Location: in Bengaluru/Bangalore
Experience: 0 to 3 yrs
Salary: INR 1,75,000 - 2,50,000 P.A
Opening(s : 5
Qualification & Duties
Must be a MSc graduate in Bioscience
0 - 3 years Sales experience.
MBA preferred
Good written and oral communication
Client follow ups
Candidate should be willing to sell services and product.
Candidates have to generate leads, qualify the leads on the sales strategies, identify the potential client, client interaction and maintain client relationship.
Understanding the requirement of client and offering them with the appropriate services and product.
Follow up with clients.
Ability to meet multiple objectives within an organization.
Work on Online marketing, Social Media Marketing, Email marketing, Tele Marketing as well as Field marketing
Selling should be your signature statement.
Maintaining relationship with clients and providing business leads, client interaction, team building, follow up with clients.
It's hard to know these days which way the proverbial worm is turning when it comes to shifts in drug policy. Election years tend to do that. Despite an historical turn of events in Central America which saw Presidents of drug trafficking nations come together to call for world wide decriminalization of drugs, in an effort to end the violence and corruption of the drug trade, the US continues to demur, absurdly claiming that the "War on Drugs" has been a success. Even stranger is Canada's recent announcement that they plan to follow the US model of a "tough on crime" approach to drug policy, which threatens to swell their correctional system in the same ways as in the US. Still, good news abounds with recent studies showing that LSD can cure alcoholism, psychedelics can cure PTSD, and cannabis smoking is not nearly as harmful as the prohibition governments claim. ~ CS
To liberalise or prohibit, that is the question. And to answer it the masters of live debate have joined forces with the masters of web technology to create a never-seen-before combination of Oxford debating and Silicon Valley prowess.
Prohibitionists argue that legalising anything increases its consumption. The world has enough of a problem with legal drugs like alcohol and tobacco, so why add to the problem by legalising cannabis, cocaine and heroin?
The liberalisers say prohibition doesn’t work. By declaring certain drugs illegal we haven’t reduced consumption or solved any problem. Instead we’ve created an epidemic of crime, illness, failed states and money laundering.
Julian Assange and Richard Branson; Russell Brand and Misha Glenny; Geoffrey Robertson and Eliot Spitzer. Experts, orators and celebrities who’ve made this their cause – come and see them lock horns in a new Intelligence?/Google+ debate format. Some of our speakers will be on stage in London, others beamed in from Mexico City or Sao Paulo or New Orleans, all thanks to the “Hangout” tool on Google+.
The web will have its say, and so can you at the event in London. Be part of the buzz of the audience, be part of an event beamed across the web to millions. Come and witness the future of the global mind-clash at the first of our Versus debates, live at Kings Place
The message is (or should be deeply disturbing. Shouldn't the USA be ashamed at having the world's largest prison system and highest incarceration rate (754 per 100 000 people ? The richest country in the world has so many of its citizens in prison that it can't afford to house them with even basic minimum medical care (more than half of all prisoners have mental health or drug problems . Prison overcrowding itself has become so terrible in California, that in May, 2011, the US Supreme Court affirmed a lower court order that California release some 46 000 prisoners because of the inhuman conditions under which they were being held. In the Court's words, “A prison that deprives prisoners of basic sustenance, including adequate medical care, is incompatible with the concept of human dignity and has no place in a civilised society.”
More women are ending up behind bars than ever. Between 1980 and 1989, the number of women in U.S. prisons tripled. And the number of women in prison has continued to rise since. In the last 10 years, the number of women under jurisdiction of state or federal authorities increased 21 percent to almost 113,000. During the same time period, the increase in the number of men in prison was 6 percentage points lower, at about 15 percent. The increase in women in the federal population was even larger- over 41 percent from 2000 to 2010.
Most women are incarcerated for nonviolent offenses. Over one-fourth are in prison for a drug offense, while 29.6 percent were convicted of a property crime. Addiction plays a large part in a number of women's property crimes, and a lack of available or appropriate treatment only serves to drive their contact with the justice system.
Stephen Vittoria is that rare commodity in Hollywood today: a filmmaker with a conscience. To be more precise, a filmmaker with a strong political conscience. After making two feature films,>Black and White& Hollywood Boulevard (1996 , as well as three feature documentaries:Save Your Life -- The Life and Holistic Times of Dr. Richard Schulze (1998 ,;Keeper of the Flame (2005 and the award-winning art house hit One Bright Shining Moment: The Forgotten Summer of George McGovern (2005 , a portrait of the South Dakota senator who tried to unseat Richard Nixon from the White House in 1972.
For his latest exploration into America's socio-political landscape, Vittoria joins forces with radio producer Noelle Hanrahan to bring Long Distance Revolutionary, the story of Mumia Abu-Jamal, to the screen. Born Wesley Cook in Philadelphia, Abu-Jamal made his name as a tireless writer and journalist during the racially-charged 1970s that often portrayed the City of Brotherly Love as anything but. With his intense coverage of the MOVE organization, a black empowerment group whose ongoing battle with the police and city hall came to a fiery end in 1985, Abu-Jamal become a constant thorn in the side of the city's powerful establishment. Things came to a sudden head for Abu-Jamal himself on the evening of December 9, 1981 when he was accused of murdering a Philadelphia police officer. He received a death sentence the following year, and has been on Pennsylvania's death row until early this year, when his death sentence was commuted to a life sentence in December, 2011.
Abu-Jamal's case remains one of the most controversial and heatedly debated in American legal history, with participants on both sides either protesting his innocence in the murder of Officer Daniel Faulkner or his absolute guilt with equal passion and more often, great vehemence.
At a recent conference of journalists at John Jay College, I raised an issue I have about language in the media: the frequent use of the word “felon” to describe a person who has been convicted of a crime.
“Felon” is an ugly label that confirms the debased status that accompanies conviction. It identifies a person as belonging to a class outside many protections of the law, someone who can be freely discriminated against, someone who exists at the margins of society.
In short, a “felon” is a legal outlaw and social outcast.
Scientific theories that addiction hijacks the brain have just increased the stigma that they were meant to stop. At least in the moralistic bad old days, addicts were still viewed as having free will. Here's an alternative to both of these no-win approaches.
Mind-altering compounds, such as LSD and psilocybin, stirred controversy in the 1960s. As the counter-culture’s psychedelic drugs of choice, the widespread use - and abuse - of hallucinogens prompted tougher anti-drug laws.
No comments:
Post a Comment